Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PROSER1 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | UBTF | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | CRIM1 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | MEDAG | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
mRNA | GRN | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
mRNA | CPSF6 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | EHMT2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | SRSF2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | CDC42EP3 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
mRNA | PLK4 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |